• Nenhum resultado encontrado

Non-alcoholic fatty liver disease (NAFLD)

Non-alcoholic fatty liver disease caused by type IX glycogenosis - a series of cases in children

Non-alcoholic fatty liver disease caused by type IX glycogenosis - a series of cases in children

... is Non-Alcoholic Fatty Liver Disease (NAFLD), whose prevalence has increased dramatically in recent ...of fatty liver associated with obesity or type of diet, diagnosis of ...

24

Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease: correlation with albumin/creatinine ratio

Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease: correlation with albumin/creatinine ratio

... Objective: We assessed plasma adiponectin and its correlation with carotid intima-media-thickness (CIMT), as a marker of atherosclerosis, and urine albumin/creatinine ratio (ACR) in patients with ...

5

Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats

Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats

... Non-alcoholic fatty liver disease (NAFLD) has been a disturbing clinical ...common liver disease in China. Non-alcoholic fatty liver ...

5

Açai improves non-alcoholic fatty liver disease (NAFLD) induced by fructose.

Açai improves non-alcoholic fatty liver disease (NAFLD) induced by fructose.

... The non-alcoholic fatty liver disease (NAFLD) includes isolated hepatic steatosis and non-alcoholic steatohepatitis (NASH) and their prevalence has doubled in the last 20 ...

8

Non-alcoholic fatty liver disease: risk factors and relationship with the metabolic syndrome

Non-alcoholic fatty liver disease: risk factors and relationship with the metabolic syndrome

... The definition of the metabolic syndrome (MS) may differ according to several major organizations, such as the World Health Organization, the International Diabetes Federation, the European Group for the Study of Insulin ...

30

A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.

A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.

... Non-alcoholic fatty liver disease (NAFLD) is increasing worldwide; NAFLD is defined by sig- nificant lipid deposition in hepatocytes (exceeding 5–10% of fat-laden hepatocytes were ...

19

Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?

Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?

... infection, alcoholic and non-alcoholic fatty liver disease are the two remaining big aetiologies of chronic liver disease in need of better ...is ...

7

DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH LOW LEVELS OF FREE COPPER AND OF CERULOPLASMIN

DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH LOW LEVELS OF FREE COPPER AND OF CERULOPLASMIN

... of non-alcoholic fatty liver disease ...of non-ceruloplasmin-bound copper (NCBC) with clinical, biochemical and histological parameters of non-alcoholic ...

5

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

... Non-alcoholic fatty liver disease (NAFLD) has become one of the most prevalent chronic liver ...various liver-related and unrelated conditions such as cirrhosis, end-stage ...

16

Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease

Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease

... of non-alcoholic fatty liver disease (NAFLD) is more common worldwide and no certain treatment apart from lifestyle modification has been established ...on non-alcoholic ...

8

Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals

Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals

... Non-alcoholic fatty liver disease (NAFLD) has been pointed out as the most prevalent hepatic disease throughout the ...the liver biopsy of these patients, pure steatosis, ...

5

Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)

Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)

... Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, ...

5

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease

... with non-alcoholic fatty liver disease is associated with progression of the ...with non-alcoholic fatty liver disease and fibrosis and these ...

7

Metabolic pathway of non-alcoholic fatty liver disease: Network properties and robustness

Metabolic pathway of non-alcoholic fatty liver disease: Network properties and robustness

... of non-alcoholic fatty liver disease was produced as the following, where the row/column IDs of the matrix are, 1: IL6, 2: IL6R , 3: SOCS3, 4: TNF-, 5: TNFR1, 6: NF-B, 7: INS, 8: ...

12

EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS

EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS

... – Non-alcoholic fatty liver disease has been progressively diagnosed in the general population as a consequence of the increased prevalence of obesity and type 2 diabetes mellitus, its ...

5

NON-ALCOHOLIC FATTY LIVER DISEASE AT OUR INSTITUTE

NON-ALCOHOLIC FATTY LIVER DISEASE AT OUR INSTITUTE

... detected Non Alcoholic Fatty Liver ...as fatty liver by ultrasound imaging who attended the Department of General Medicine, Government General Hospital Kakinada Rangaraya Medical ...

5

Apoptosis and miRNAs in non-alcoholic fatty liver disease pathogenesis

Apoptosis and miRNAs in non-alcoholic fatty liver disease pathogenesis

... free fatty acids activate JNK1/c-Jun pathway inducing PUMA transcriptional up-regulation with subsequent Bax activation as integral steps promoting saturated free fatty acid-mediated apoptosis (Cazanave et ...

217

The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease

The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease

... Methods: This double-blind randomized placebo-controlled clinical trial was conducted on 60 NAFLD patients from specialized clinics of Tabriz University of Medical Sciences from December 2011 to July 2012. The subjects ...

9

Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.

Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.

... for non-alcoholic fatty liver dis- ease ...chronic liver disease, which includes a spectrum of hepatic pathologies and can involve ...in alcoholic liver ...

17

The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data

The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data

... In summary, the administration of saxagliptin treatment could effectively control blood glucose in patients newly diagnosed with T2DM combined with NAFLD, and its efficacy was no worse than that of glimepiride. In ...

5

Show all 9062 documents...

temas relacionados